Navigation Links
NxStage Announces Investor Conference Schedule
Date:8/6/2008

LAWRENCE, Mass., Aug. 6 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer, will participate in the following schedule of investor conferences. Where possible, a webcast of each event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference.

Canaccord Adams Annual Global Growth Conference

Boston, MA

InterContinental Boston Hotel

Tuesday, August 12, 2008

9:00 a.m. EDT

Thomas Weisel Partners Healthcare Conference

Boston, MA

Four Seasons Hotel

Friday, September 5, 2008

8:35 a.m. EDT

UBS Global Life Sciences Conference

New York, NY

Grand Hyatt Hotel

Monday, September 22, 2008

Time to be determined.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Privat
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population
2. NxStage Medical to Present at William Blair Growth Stock Conference
3. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
4. NxStage Medical Announces Needle Supply Agreement with DaVita
5. NxStage Medical to Present at the Piper Jaffray Healthcare Conference on November 27, 2007
6. Arbios Announces SEPET(TM) Manufacturing Agreement With NxStage Medical
7. NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd
8. NxStage Medical Provides Update on Medisystems Acquisition
9. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
10. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
11. China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... three Department of Energy (DOE) bio-energy research centers, has ... valuable intellectual property. , ... ... Surety, LLC , the leading provider of ... Joint BioEnergy Institute (JBEI), one of three Department of ...
(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...
(Date:12/15/2009)... 15 On January 20th, 2010, the ... Medical Publication Professionals (ISMPP) will be held at ... More than 100 attendees are expected at this ... professionals, editors, publishers, medical writers and medical agencies ... and the impact of guidelines and regulations such ...
(Date:12/14/2009)... FREMONT, Calif., Dec. 14 Vermillion, ... company, today announced William C. Wallen, Ph.D. ... and Development for IDEXX Laboratories, will be ... of Vermillion,s bankruptcy plan. ,, "Bill ... development experience in diagnostics and biotechnology," said ...
Breaking Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... Phase 3 Registration Trial No Later Than ... ... a biopharmaceutical company developing patient-specific, active,immunotherapies for the treatment of cancer, today ... the quarter and year,ended December 31, 2007, the Company reported net losses ...
... Developing a credit-card-sized gas chromatography platform that ... next step for Virginia Tech College of Engineering ... Science Foundation (NSF) Faculty Early Career Development Program ... an assistant professor in the Bradley Department of ...
... First Choice Professionals, LLC.,today announced the addition of ... Mark will join FCP as Program,Management Office and ... of Healthcare IT thought leadership,experience to FCP. Prior ... of systems support at Catholic Healthcare West. Prior ...
Other Biology Technology:Favrille Reports Fourth Quarter and Year End 2007 Financial Results 2Favrille Reports Fourth Quarter and Year End 2007 Financial Results 3Favrille Reports Fourth Quarter and Year End 2007 Financial Results 4Favrille Reports Fourth Quarter and Year End 2007 Financial Results 5Favrille Reports Fourth Quarter and Year End 2007 Financial Results 6Favrille Reports Fourth Quarter and Year End 2007 Financial Results 7Favrille Reports Fourth Quarter and Year End 2007 Financial Results 8Favrille Reports Fourth Quarter and Year End 2007 Financial Results 9Credit-card-sized platform for volatile compound analysis CAREER project goal 2FCP Welcomes Mark Scherling 2
(Date:12/15/2009)... - Scientists at VIB and Ghent University in Flanders, ... of septic shock, the major cause of death in ... oxide (NO) gas in mice with septic shock, researchers ... organs showed much less damage, while their chances of ... it is generally assumed that nitric oxide is responsible ...
(Date:12/15/2009)... This release is available in German ... laws everywhere across the globe, cultures vary as to ... example, do not use egocentric terms such as ,left, ... using allocentric notions like ,north, south, east, west, at ... of the bowl" or "There is an snake by ...
(Date:12/15/2009)... This release is available in German ... use in predicting the future distribution of mammals. This ... niches of 140 indigenous European mammals. The researchers analysed ... as well as the phylogenetic information of the species. ... for closely related species, mammals seem to adapt fast ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Species distribution models are of only limited value for predicting future mammal distributions 2Private and public insurance choices could help pay for national health care reform 51976 1Private and public insurance choices could help pay for national health care reform 51976 2Private and public insurance choices could help pay for national health care reform 51976 3Baylor Dallas Recognized In U S News Media Groups 2009 2010 Americas Best Hospitals 51971 1Baylor Dallas Recognized In U S News Media Groups 2009 2010 Americas Best Hospitals 51971 2Baylor Dallas Recognized In U S News Media Groups 2009 2010 Americas Best Hospitals 51971 3Justice Department Releases New Fact Sheet on the Rights of Persons With HIV or AIDS to Obtain Occupational Training and State Licensing 51967 1
... a study to be published in the January 2006 ... of scientists at Memorial Sloan-Kettering Cancer Center have devised ... and RNA interference to genetically reverse sickle cell disease ... to demonstrate a way to genetically correct this debilitating ...
... helping to spread spores of pathogen , Biologists studying ... Columbia present strong evidence in the September issue of ... outbreak. The blight, caused by the fungus Dothistroma septosporum, ... case of the British Columbia outbreak, eventually die. D. ...
... between advantage and disadvantage , Some viruses' ability to ... replication may be both a blessing and curse, according ... at the Johns Hopkins Bloomberg School of Public Health. ... antibody-dependent enhancement may allow the dengue virus to grow ...
Other Biology News:Sickle cell disease corrected in human models using stem cell-based gene therapy 2Computer models aid understanding of antibody-dependent enhancement in spread of dengue fever 2
The SmartSpec printer paper is used to record data generated by the SmartSpec Plus spectrophotometer. Supplied as 5 packs....
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
... Assay with FAM-Labeled Substrate (green fluorescence; ... measure serine protease activation • No ... FLISP Kits utilize cell-permeable, fluorescently labeled ... measure chymotrypsin-like activity in whole living ...
Request Info...
Biology Products: